09.02.2016 - Martin Shkreli, the 32-year-old former CEO of Turing Pharmaceuticals who made negative headlines last year after jacking up the price of the toxmoplasmosis drug Daraprim...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)